Your browser doesn't support javascript.
loading
Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1ß Expression in Primary Mouse Cardiac Fibroblasts.
Torp, May-Kristin; Yang, Kuan; Ranheim, Trine; Husø Lauritzen, Knut; Alfsnes, Katrine; Vinge, Leif E; Aukrust, Pål; Stensløkken, Kåre-Olav; Yndestad, Arne; Sandanger, Øystein.
Afiliación
  • Torp MK; Division of Physiology, Department of Molecular Medicine, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Yang K; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
  • Ranheim T; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
  • Husø Lauritzen K; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Alfsnes K; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
  • Vinge LE; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Stensløkken KO; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
  • Yndestad A; Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Sandanger Ø; Centre for Heart Failure Research, University of Oslo, Oslo, Norway.
Front Immunol ; 10: 1285, 2019.
Article en En | MEDLINE | ID: mdl-31244838
Background: IL-1ß is a highly potent pro-inflammatory cytokine and its secretion is tightly regulated. Inactive pro-IL-1ß is transcribed in response to innate immune receptors activating NFκB. If tissue damage occurs, danger signals released from necrotic cells, such as ATP, can activate NLRP3-inflammasomes (multiprotein complexes consisting of NLRP3, ASC, and active caspase-1) which cleaves and activates pro-IL-1ß. NLRP3 activation also depends on NEK7 and mitochondrial ROS-production. Thus, IL-1ß secretion may be regulated at the level of each involved component. We have previously shown that NLRP3-dependent IL-1ß release can be induced in cardiac fibroblasts by pro-inflammatory stimuli. However, anti-inflammatory mechanisms targeting IL-1ß release in cardiac cells have not been investigated. mTOR is a key regulator of protein metabolism, including autophagy and proteasome activity. In this study we explored whether autophagy or proteasomal degradation are regulators of NLRP3 inflammasome activation and IL-1ß release from cardiac fibroblasts. Methods and Results: Serum starvation selectively reduced LPS/ATP-induced IL-1ß secretion from cardiac fibroblasts. However, no other inflammasome components, nor mitochondrial mass, were affected. The mTOR inhibitor rapamycin restored pro-IL-1ß protein levels as well as LPS/ATP-induced IL-1ß release from serum starved cells. However, neither serum starvation nor rapamycin induced autophagy in cardiac fibroblasts. Conversely, chloroquine and bafilomycin A (inhibitors of autophagy) and betulinic acid (a proteasome activator) effectively reduced LPS-induced pro-IL-1ß protein levels. Key findings were reinvestigated in human monocyte-derived macrophages. Conclusion: In cardiac fibroblasts, mTOR inhibition selectively favors pro-IL-1ß synthesis while proteasomal degradation and not autophagy is the major catabolic anti-inflammatory mechanism for degradation of this cytokine.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Expresión Génica / Interleucina-1beta / Inflamasomas / Serina-Treonina Quinasas TOR / Fibroblastos Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Expresión Génica / Interleucina-1beta / Inflamasomas / Serina-Treonina Quinasas TOR / Fibroblastos Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article